These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27474775)

  • 1. Rivaroxaban Therapy, False-Positive Lupus Anticoagulant Screening Results, and Confirmatory Assay Results.
    Murer LM; Pirruccello SJ; Koepsell SA
    Lab Med; 2016 Nov; 47(4):275-278. PubMed ID: 27474775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. False-positive lupus anticoagulant in patients receiving rivaroxaban: 24 h since the last dose are needed to exclude antiphospholipid syndrome.
    Góralczyk T; Iwaniec T; Wypasek E; Undas A
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):473-5. PubMed ID: 25402189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: A real-life study.
    Gay J; Duchemin J; Imarazene M; Fontenay M; Jourdi G
    Int J Lab Hematol; 2019 Dec; 41(6):738-744. PubMed ID: 31487115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome.
    Arachchillage DR; Mackie IJ; Efthymiou M; Isenberg DA; Machin SJ; Cohen H
    J Thromb Haemost; 2015 Jul; 13(7):1264-73. PubMed ID: 25850997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus-anticoagulant testing at NOAC trough levels.
    Ratzinger F; Lang M; Belik S; Jilma-Stohlawetz P; Schmetterer KG; Haslacher H; Perkmann T; Quehenberger P
    Thromb Haemost; 2016 Aug; 116(2):235-40. PubMed ID: 27075441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent false-positive results of lupus anticoagulant tests in plasmas of patients receiving the new oral anticoagulants and enoxaparin.
    Martinuzzo ME; Barrera LH; D 'adamo MA; Otaso JC; Gimenez MI; Oyhamburu J
    Int J Lab Hematol; 2014 Apr; 36(2):144-50. PubMed ID: 24034808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.
    Ząbczyk M; Kopytek M; Natorska J; Undas A
    Clin Chem Lab Med; 2019 Aug; 57(9):1374-1381. PubMed ID: 30763261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients.
    Moore GW; Culhane AP; Maloney JC; Archer RA; Breen KA; Hunt BJ
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):477-80. PubMed ID: 26656903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfa.
    Favaloro EJ; Gilmore G; Arunachalam S; Mohammed S; Baker R
    Thromb Res; 2019 Aug; 180():10-19. PubMed ID: 31158643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives.
    Favaloro EJ; Mohammed S; Curnow J; Pasalic L
    Pathology; 2019 Apr; 51(3):292-300. PubMed ID: 30665674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of lupus anticoagulant in the era of direct oral anticoagulants.
    Hoxha A; Banzato A; Ruffatti A; Pengo V
    Autoimmun Rev; 2017 Feb; 16(2):173-178. PubMed ID: 27988438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants.
    Jourdi G; Delrue M; Stepanian A; Valaize J; Foulon-Pinto G; Demagny J; Duchemin J; Nedelec-Gac F; Darnige L; Curis E; Delavenne X; Gaussem P; Siguret V; Gouin-Thibault I
    Thromb Res; 2019 Dec; 184():86-91. PubMed ID: 31710863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population.
    Lambert M; Ferrard-Sasson G; Dubucquoi S; Hachulla E; Prin L; Hatron PY; Goudemand J; Boffa MC; Caron C
    Thromb Haemost; 2009 Mar; 101(3):577-81. PubMed ID: 19277423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consultative Interpretation for Lupus Anticoagulant by Expert Pathologist Reduces False-Positive Rates in the Era of Direct Oral Anticoagulants.
    Vivero A; Kitahara S; Runge A; Volod O
    J Appl Lab Med; 2020 Jan; 5(1):73-82. PubMed ID: 31811080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Indirect- and Direct-Acting Anticoagulants on Lupus Anticoagulant Assays: A Large, Retrospective Study at a Coagulation Reference Laboratory.
    Seheult JN; Meyer MP; Bontempo FA; Chibisov I
    Am J Clin Pathol; 2017 Jun; 147(6):632-640. PubMed ID: 28525532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct thrombin inhibitors and factor xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant.
    Olah Z; Szarvas M; Bereczky Z; Kerenyi A; Kappelmayer J; Boda Z
    Arch Pathol Lab Med; 2013 Jul; 137(7):967-73. PubMed ID: 23808469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation.
    Jennings I; Kitchen S; Woods TA; Preston FE; Greaves M
    Thromb Haemost; 1997 May; 77(5):934-7. PubMed ID: 9184405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixing studies in lupus anticoagulant testing are required at least in some type of samples.
    Devreese KM; de Laat B
    J Thromb Haemost; 2015 Aug; 13(8):1475-8. PubMed ID: 26017873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.